Company / Depreciation & Amortization
MANNKIND CORP Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$12.3M
FY2025
5-year range
$2.0M / $12.3M
FY2021-FY2025
Trend
+66.7%
vs FY2024
Sector context
#57 of 162
Health Care
What the data says
At $12M, MANNKIND CORP's depreciation & amortization ranks #106 of 162 in the Health Care sector. Depreciation & Amortization has increased for 4 consecutive years, from $2M in FY2021 to $12M in FY2025.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of +41.7%.
Increased from $5M to $12M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +54.6%
- 5-Year CAGR
- +41.7%
- 10-Year CAGR
- -
Sector benchmark
#106 of 162 in Health CareTop 65% of 162This company $12.3M Sector average $220.5M
▼
-94.4% below sector average
Key checks
Key Insights
- MANNKIND CORP's depreciation & amortization has grown for 4 consecutive years.
- 5-year CAGR of +41.7%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 66.7% year-over-year.
- Ranks #57 out of 162 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.3M | +66.7% |
| FY2024 | $7.4M | +62.5% |
| FY2023 | $4.5M | +36.4% |
| FY2022 | $3.3M | +67.4% |
| FY2021 | $2.0M | -7.6% |
| FY2020 | $2.1M | +121.1% |
| FY2019 | $972.0K | -66.0% |
| FY2018 | $2.9M | +58.7% |
| FY2017 | $1.8M | -25.0% |
| FY2016 | $2.4M | -78.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026